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ABSTRACT 
Pterygium is a frequent corneal disease characterized by growing of fibrovascular tissue from the bulbar conjunctiva onto 
the cornea. Although the causes of pterygium are not obvious, sun exposure is closely correlated with its development. 
Pterygium, especially double-headed pterygium is mostly seen in warm climate and in individuals who work outdoors. A 
minority of pterygium is double-headed (both temporal and nasal origins). Bilateral recurrent double-headed pterygium is 
a very rare condition. Here, we reported a 35-year-old male patient with bilateral recurrent double-headed pterygium. A 
brief review about the recent literature concerning the etiology, associated risk factors, operation types and management 
of patients with recurrent pterygium was also discussed. The patient was a field worker, smoker and had a family history of 
pterygium. There was no ocular surgery history except pterygium surgery 15 years ago in both eyes. A successful 
pterygium excision was performed under local anesthesia with the vertical split conjunctival autograft transplantation 
(CAT) in both temporal and nasal parts of the right eye (randomly) for cosmetic disfigurement and avoidance of 
recurrence. The pathological report was consistent with pterygium. At postoperative first week, first and 1.5th month visits, 
conjunctival autografts were in place and stable. No complications such as infection, corneal thinning or graft dislocation 
were seen. The patient was satisfied with his right eye and demanded the same surgery for his left eye. We suggest vertical 
split simultaneous CAT as a safe and useful surgical method for the treatment of recurrent double-headed pterygium; 
however, longer follow-up is required to confirm the outcome. 
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INTRODUCTION
Pterygium is one of the leading causes of blindness and 
visual disorder [1, 2]. It is known as a widespread 
fibrovascular wedge-like lesion of the epithelial tissue 
invading cornea [3-8]. Pterygium usually occurs due to 
chronic ultraviolet exposure and develops at the nasal part 
of the cornea (97%) [3]. A rare type of pterygium is double-
headed (both temporal and nasal origins) and bilateral form 
which is scarcely seen [3]. There is only one paper in the 
literature regarding pterygium-like corneal alterations of 
three patients in one family complained from persistent 
recurrences with bilateral symmetrical involvement of the 
nasal and temporal cornea [9]. Double-headed pterygium 
contradicts the surgeon regarding simultaneous or two-
stage surgery [3, 4]. Different surgical techniques for 
treatment of double-headed pterygium have been applied 
[3, 4]. Perfect pterygium surgery should achieve a low or no 
recurrence rate, negligible complications and good cosmetic 
outcome [3, 4].  
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In this manuscript, an interesting rare case of a bilateral 
double-headed recurrent pterygium and vertical split 
conjunctival autograft transplantation (CAT) 
simultaneous surgery (to both nasal and temporal parts 
of the right eye) was presented.  A brief review about the 
recent literature published in Pubmed without language 
and time restrictions concerning the etiology, associated 
risk factors, operation types and management of patients 
with recurrent pterygium was also discussed. 
CASE REPORT 
A 35-year-old male patient, referred to our clinic for his 
bilateral recurrent double-headed pterygium for 15 
years. He was a field worker, smoker and had a family 
history of pterygium. He told that his mother and sister 
had also pterygium. His visual acuity was full in both 
eyes. On slit-lamp examination, he had bilateral 
recurrent double headed pterygium. Slit photo of the 
patient was taken (Figure 1). In the right eye, recurrent 
pterygium in temporal side was larger than the nasal 
side, unexpectedly. The other ophthalmic findings were 
unremarkable. Schirmer test was also applied and both 
eye values were 30 mm. Intraocular pressures were 16 
mmHg by noncontact tonometer in both eyes. Posterior 
segment exams had normal findings. Optical coherence 
tomography images of both eyes were shown in Figure 2. 
He had no history of any ocular surgery except for 
pterygium surgery 15 years ago in both eyes. He did not 
remember the method of previous pterygium surgery 
and his past medical documents were not available. He 
had no history of ocular trauma, systemic disease or 
medication. Routine laboratory findings revealed positive 
results for hepatitis B surface antigen. We referred the 
patient to the gastroenterology department for further 

















Figure 1. Double-Headed Bilateral Recurrent Pterygium at His First 
Presentation to Our Clinic 
 
We decided to apply surgery randomly to the right eye a 
week later following consulting the patient. Successful 
excision for double-headed pterygium was made under local 
anesthesia in the right eye after receiving a signed informed 
consent. Following instillation of topical proparacaine 
hydrochloride 0.5% (Alcaine; Alcon Canada, Couvreur, 
Belgium), the sterile preparation and draping were applied to 
the right eye, and then a lid speculum was inserted. The 
bodies of the nasal and temporal pterygium were marked. 
Temporal pterygium was larger and excised firstly. 
Subconjunctival lidocaine hydrochloride + 2% epinephrine 
was injected into the pterygium head. The pterygium was 
excised from the cornea by using toothed forceps and 
crescent blade. Complete dissection of the pterygium body 
from the sclera, subconjunctival Tenon’s tissue and 
surrounding fibrovascular tissues was performed with the 
Westcott scissors. Homeostasis was achieved without using 
cauterizing. The conjunctival edge was trimmed. The corneal 
surface was gently scraped with a scalpel. After performing 
the same procedure on the nasal pterygium, a single piece of 
conjunctival tissue was taken from the superior bulbar 
conjunctiva of the same eye and divided into two pieces 
vertically based on the area of the removed pterygium and 
placed leaving no open scleral tissue starting from the nasal 
and temporal limbus, with the epithelial side up and the 
limbal area aligned with the limbus. Drugs to avoid recurrence 
like mitomycin C or 5-fluorouracil were not used. Both grafts 
were sutured to the surrounding conjunctiva by interrupted 
7/0 vicryl. The excised pterygium specimen was sent for 
pathological investigation. Photograph of the right eye was 
taken at the end of operation (Figure 3). Following operation, 
therapeutic bandage contact lens was placed. 
Postoperatively, the patient received 0.5% loteprednol 
etabonate + tobramycin (Zylet, Bausch and Lomb, Rochester, 
NY, The USA) 4 times a day, bacitracin + neomycin sulfate 
ophthalmic ointment (Thiocilline, Abdi İbrahim, İstanbul, 
Turkey) twice daily, lubricant eye drop (Systane, Alcon 
Laboratories, Inc., Fort Worth, TX, The USA) for 10 days. In 
addition, 0.05% cyclosporin A (Restasis, Allergan 
Pharmaceutical, Irvine, CA, The USA) twice daily was 
prescribed for 6 weeks postoperatively. Patient was 
recommended to avoid dusty and sunny environments and to 
use sunglasses. The pathological report was consistent with 
pterygium. At the postoperative first week, first and 1.5-
month visits, conjunctival autografts were in place and stable. 
No complications such as infection, corneal thinning or graft 
dislocation were seen during the 1.5-month follow-up. 
Therapeutic bandage contact lens was removed at the end of 
first month. He was satisfied with his right eye and demanded 
the same surgery for his left eye. Postoperative 1.5-month 
clinical photograph was shown in Figure 4. 
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Figure 2. Optical Coherence Tomography Images of Both Eyes With Normal Appearance of Both Macular Area. 
 
 
Figure 3. Patient’s Right Eye at the End of Operation. (N: Nasal; T:  
Temporal. Arrows show conjunctival autografts in place. 
 
 
Figure 4. Slit-lamp photograph of the patient’s right eye at the 
postoperative 1.5-month, showing fine corneal opacity in nasal and 
temporal sides of peripheral cornea. But, no complications such as 
infection, corneal thinning or graft dislocation were seen. 
 
DISCUSSION 
This patient was presented because of the rare incidence 
of bilateral, recurrent and double side corneal 
involvement. A successful pterygium excision was 
performed under local anesthesia with the vertical split 
CAT to both temporal and nasal parts of the right eye for 
cosmetic purposes and avoiding recurrence.  
Ethnicity is associated with development of pterygium. 
Chen T et al. [10] showed that Han ethnicity is a 
significant risk factor of pterygium. In other studies, the 
primary risk factors for pterygium were reported as age, 
male sex, ultraviolet exposure, outdoor work and 
smoking [11-23]. Pterygium has been reported also as a 
work-related disorder [24]. Our patient was a male field 
worker and smoker living in Hatay (a sunny city located in 
the southernmost of Turkey). In contrast to above 
studies, unexpectedly, outdoor occupations were not 
found as a risk factor for pterygium in the study of 
Akinsola FB et al. [25]. Malekifar P et al. [26] 
demonstrated that family history of pterygium and 
blepharitis found to be risk factors. Our patient had also 
a positive family history, but no blepharitis. Roka N et al. 
[27] mentioned a strong association between dry eye and 
pterygium. Dry eye was not an accompanying entity in 
our patient. 
Double-headed pterygium enforces the surgeon about a 
simultaneous or two-stage surgery [3, 4]. Different 
surgical techniques for double-headed pterygium have 
been performed [3, 4]. Perfect pterygium surgery should 
achieve a low or no recurrence rate, negligible 
complications and good cosmetic purpose [3, 4].  CAT 
technique with a recurrence rate of 5% has been the 
most preferred one used by ophthalmologists for years 
[3-5], which was applied for our patient. In another study 
authors mentioned that sutured limbal conjunctival 
autografts had a recurrence rate ranging from 0% to 
14.29% [9]. Dividing the free conjunctival autograft into 
two parts and suturing in place of the excised pterygium 
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on both side of the corneas seems to be a good choice in 
double headed pterygium [3]. 
Yeung SN et al. [5] performed sequential pterygium 
excision with CAT in the management of double-headed 
pterygium. They mentioned that CAT from the same site 
several months later does not appear to increase the rate 
of recurrence and sequential CAT is a safe and effective 
method of addressing double-headed pterygium [5]. 
Our patient was a young man and had a cosmetic worry; 
additionally, he had bilateral recurrent double-headed 
pterygium. It would take time to recovery and he did not 
want to waste time for each surgery for both eyes. 
Aidenloo NS et al. [6] suggested that young 
age, recurrent type of pterygium, and larger pterygial 
tissue are risk factors for pterygium recurrence after 
surgical excision. The recurrent pterygium was larger in 
temporal side in our patient’s right eye unexpectedly. 
They also recommended early excision of pterygium to 
reduce the recurrence rate. In the study of Lee JS et al. 
[7] authors reported that pterygium excision with a large 
conjunctival autograft for the treatment of recurrent 
pterygium provided an excellent cosmetic result, a low 
recurrence rate and minimal complications. 
Anti-fibroproliferative application with 5-fluorouracil or 
mitomycin C may be a useful adjunct in primary 
pterygium surgery [28, 29]. However, we did not prefer 
anti-fibroproliferative application because of double 
sided pterygium. In a study, no significant recurrence 
rate was found between the application of sutures and 
fibrin glue for CAT [30]. We had no fibrin glue in our clinic 
available. Therefore, we used 7/0 vicryl sutures for CAT. 
Multi-layer amniotic membrane graft for pterygium was 
also mentioned [31]. Pterygium in our patient was not in 
an advanced size; therefore, we did not need to use 
multi-layer amniotic membrane. 
Corneal perforation related with dellen is a rare but 
important complication of a pterygium excision. A 60-
year-old man with these complications was reported by a 
bare sclera technique without adjunctive therapy 
[32].  CAT is reliable, uncomplicated, fast surgery without 
loss of tissue and prevents recurrence of pterygium. It 
also decreases the risk of granuloma formation, scleral 
thinning and necrosis [33, 34]. Deep lamellar 
keratoplasty with conjunctival autograft for recurrent 
advanced pterygium correlated with corneal thinning 
was mentioned [35]. Corneal thinning or any other 
complication was not seen by CAT in our patient 1.5-
month postoperatively. 
Pterygium formation was found strongly associated with 
its location and laterality [36]. our patient had a bilateral 
pterygium and did not have amblyopia or eccentric 
fixation. A case of a free cyst of iris, bilateral pterygium 
and symmetrical nodosity of the auricle has been 
previously published [37]. There were no other 
ophthalmic or systemic pathologies in our case. 
Greater protrusion degree might be a risk factor for 
occurrence of pterygium [38]. Here, the greater 
protrusion was not seen and there was no advanced 
form of pterygium in our patient. Postoperative 
medication is important and instillation of 0.05% 
cyclosporine is safe and efficient [39]. We also offered 
patient to use postoperative 0.05% cyclosporine for 6 
weeks. Wearing of face caps/hats and protective goggles 
were found to have a protective effect [40, 41]. Patient 
was recommended to abstain from sunny conditions and 
to use sunglasses. 
To the best of our knowledge, this was the second case 
presentation of bilateral double double-headed 
pterygium with successful short term management. We 
had some limitations. Firstly, the pterygium excision for 
the left eye has not been planned yet and post-operative 
follow-up period is not long enough. It would be great if 
we could present both eyes after surgery and long 
follow-up. Secondly, a bilateral pterygium was presented 
in a 50-year-old male with H syndrome [42], patients 
with xeroderma pigmentosum [31, 43, 44], and dominant 
hereditary transmission of early adult pterygium [45]. 
The patient’s mother and sister had also pterygium. 
However, a genetic mutation analysis was not performed 
in our patient. Future studies with meticulous genetic 
mutation analysis and longer follow-up are 
recommended. 
CONCLUSION  
We suggest vertical split simultaneous CAT as a safe and 
effective surgical technique for the treatment of 
recurrent double-headed pterygium. Family history, 
sunlight exposure, male gender and smoking were the 
main significant risk factors for pterygium in our patient. 
Postoperative medication is also important and using 
sunglasses for protection from ultraviolet should be 
advised to patients with pterygium to lessen the 
recurrence probability. 
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